Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to ...

P reclinical research findings from the University of North Carolina Lineberger Comprehensive Cancer Center have identified a cocktail of three different drugs that can be used to generate more ...

Barbara Savaldo, MD, Ph.D., and colleagues at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine report that results from an early-phase clinical trial demonstrated CAR-T ...

G1 Therapeutics (G1), a company based on discoveries made at the UNC Lineberger Comprehensive Cancer Center, will use the new financing to accelerate clinical development of its lead CDK4/6 inhibitor ...

Preclinical research findings from UNC Lineberger Comprehensive Cancer Center identified a cocktail of three different drugs that can be used to generate more robust immune system CAR-Ts (chimeric ...

People with metastatic cancer who regularly report their symptoms via a home-based electronic monitoring system experienced improved quality of life, clinical outcomes and well-being, as well as fewer ...

an associate professor of medicine and researcher at the University of North Carolina's Lineberger Comprehensive Cancer Center. Herceptin is one of a new class of drugs called monoclonal ...

“CAR-T cells produced in the lab for reinfusion can be extremely different from one patient to another and the lack of certain types of cells in the end product can significantly reduce the ...

Researchers have discovered a three-drug combination that enhances the generation of CAR-T cells, a type of cancer immunotherapy, and could improve CAR-T cell production for clinical treatments.